Recording intelligenceAI-generated brief · check the source for context

Mitochondrial Transfer in Cancer Metastasis

1:02:03 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode

Brief overview

Cancer cells swap mitochondria to disarm T cells, and PD-L1's cis partnership with CD80 drives dendritic migration.

  1. Cancer cells steal good mitochondria and hand back broken onesTumour cells siphon working mitochondria from neurons and T cells, then donate mutant ones that resist mitophagy, leaving T cells exhausted.
  2. USP30 marks a possible therapeutic vulnerabilityUSP30 protects cancer mitochondria from degradation, so blocking nanotube or vesicle transfer alongside checkpoint therapy improved outcomes in the paper.
  3. PD-L1 needs CD80 on its own cell to signal migrationMixing CD80-deficient with PD-L1-deficient cells, or using soluble CD80, gave no migration — the cis pairing with intracellular domains is required.
Executive Summary AI
  • Cindy Leifer opens with a 2025 Nature paper, Nerve to Cancer Transfer of Mitochondria During Cancer Metastasis, in which glioblastoma cells throw tunneling nanotubules into neurons like a straw and siphon off mitochondria to feed their high metabolic rate.4:46
  • A second paper, Intercellular Nanotubes Mediate Mitochondrial Trafficking Between Cancer and Immune Cells (Nature Nanotechnology, 2022), shows cancer cells hijacking mitochondria from T cells, which are themselves highly energetic and switch to fast but inefficient glycolysis.9:41
  • The third paper, Immune Evasion Through Mitochondrial Transfer in the Tumor Microenvironment (Nature, 2023), finds cancer cells take working mitochondria from tumor-infiltrating lymphocytes and donate back mutant ones kept from mitophagy by USP30, leaving T cells homoplasmic, exhausted and senescent.12:42
  • Brianne Barker then presents a Science Advances paper from the University of Colorado, first-authored by her former lab member Uma Kinteti, called PD-L1-CD80 Interactions are Required for Intracellular Signaling Necessary for Dendritic Cell Migration.27:30
  • Anti-PD-L1 antibody stops dendritic cells migrating while anti-PD-1 does not, because PD-L1 must interact in cis with CD80 on the same dendritic cell, which explains why anti-PD-L1 fails against melanoma yet ameliorates psoriasis in mice.37:49
Key Quote
“But disinformation is when you purposely mislead people, like saying the polio vaccine kills more people than it helps, which is complete disinformation.”
— Vincent Racaniello2:11
Key Quote
“So they want to steal the mitochondria from their neighboring cells.”
— Cindy Leifer13:42
Key Quote
“So if they don't have CD80 and PD-L1 on the same cell, the cells can't migrate.”
— Brianne Barker50:52